IBUPROFEN THIOETHER AS INHIBITOR DEPENDING UPON NF-KB FORMATION OF INFLAMMATION AND PAIN MEDIATORS

摘要

FIELD: medicine. SUBSTANCE: the innovation in question deals with medicinal preparation containing CoA-thioethers of arylpropionic acids, arylacetic acids or acetylsalicylates, R-ibuprofen or ibuprofen racemates containing up to 49% S-ibuprofen, or derivatives of the above-mentioned compounds similarly metabolized in the body. The innovation should be used for indications of acute or/and chronic pain, inflammations of any origin and for counteraction to all other symptoms of inflammatory processes. The suggested medicinal preparation prevents prostaglandins' synthesis as a result of inflammatory processes. EFFECT: higher efficiency. 5 cl, 2 dwg